News & Media

Welcome to the Calico media center with features on our R&D efforts as well as our official press releases. For media inquiries, please email

Select a category


Press Releases

Featured Press

April 26, 2023

Calico Life Sciences Announces First Participant Dosed in Phase 1b Clinical Study Evaluating ABBV-CLS-7262 for the Treatment of Vanishing White Matter Disease

More Press Releases

Sort by